Prostate cancer is the second leading cause of cancer death in men in Western Europe and the United States.
To study whether the effect of early detection and treatment of prostate cancer may reduce the disease-specific mortality a randomized trial is initiated in Europe.

The "European Randomized study of Screening for Prostate Cancer" is a major European effort with 8 participating countries. The study has a co-operation with the Prostate Lung Colonrectal and Ovarian Cancer Screening Trial in the US.

This study should result in advice to governments around the world as to whether screening for prostate cancer should be a part of the general provision of health care to our populations.

The ERSPC, Frequently Asked Questions